Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Abogen Biosciences
company
About
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $300M
- Industries
- Biotechnology,Genetics,Life Science
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.30B
Abogen Biosciences has raised a total of
$1.30B
in funding over 2 rounds. Their latest funding was raised on
Nov 29, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 29, 2021 | Series C | $300M | 3 | — | — | Detail |
| Aug 19, 2021 | Series C | $1B | 3 |
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
Abogen Biosciences is funded by 6 investors.
Lilly Asia Ventures
and MiraeAsset Financial Group
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Series C |
|
|
— | Series C |
|
|
— | Series C |
|
|
— | Series C |
Abu Dhabi Investment Authority
|
— | Series C |
Gaorong Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
